Clinical Trial Update: Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tamoxifen to thalidomide in women with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer has completed enro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Epithelial Cancer
• Peritoneal Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)
• Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-09-16